CLVT Stock: Price, Forecast, Financials & AI Analysis

Loading...

Loading chart...

High

2.570

Open

2.460

VWAP

2.47

Vol

15.18M

Mkt Cap

1.60B

Low

2.330

Amount

37.49M

EV/EBITDA(TTM)

6.01

Total Shares

639.22M

EV

5.61B

EV/OCF(TTM)

9.48

P/S(TTM)

0.66

Clarivate Plc is a provider of transformative intelligence. The Company offers intelligence solutions, workflow solutions, and tech-enabled services to its customers. It operates through three segments, which include Academia & Government (A&G), Intellectual Property (IP), and Life Sciences & Healthcare (LS&H). The Academia & Government segment connects trusted content, responsible technology, and editorial expertise to fuel academic success and advance national outcomes for institutions and users around the world. The Intellectual Property segment provides intellectual property data, software, and helps companies drive innovation, law firms achieve practice excellence, and organizations manage and protect critical intellectual property assets. The Life Sciences & Healthcare segment offers life sciences and healthcare organizations with the contextual intelligence needed to deliver safe and commercial treatments and solutions to patients.

Show More

Events Timeline

(ET)

2026-07-06

16:30:00

Major Averages Open Higher as Chip Stocks Rebound

2026-07-06

13:30:00

Chip Stocks Rebound Boosts Major Averages

2026-07-06

06:30:00

Clarivate Reaffirms FY26 Revenue Outlook of $2.3B to $2.42B

2026-07-06

06:30:00

Clarivate Divests Life Sciences & Healthcare Segment for $600M

2026-05-19 (ET)

2026-05-19

05:10:00

Clarivate Signs Ten-Year Agreement with Czech National Library of Technology

2026-04-29 (ET)

2026-04-29

06:10:00

Company Reports Q1 Revenue of $585.5M, Beating Expectations

2026-04-29

06:10:00

Company Reaffirms FY26 Revenue Outlook of $2.3B to $2.42B

2026-03-10 (ET)

2026-03-10

05:10:00

Clarivate Partners with Claude to Integrate Regulatory Intelligence

News

Newsfilter

07-06Newsfilter

PinnedClarivate Divests Life Sciences & Healthcare Segment for $600 Million

seekingalpha

07-06seekingalpha

Clarivate Shares Surge 16% on $600M Life Sciences Divestiture Agreement

PRnewswire

07-06PRnewswire

Clarivate Divests Life Sciences & Healthcare Segment for $600 Million

PRnewswire

07-06PRnewswire

Clarivate Divests Life Sciences & Healthcare Segment for $600 Million

PRnewswire

06-23PRnewswire

Clarivate Releases 2025 Sustainability Report Highlighting Carbon Emission Reductions

Newsfilter

06-23Newsfilter

Clarivate Releases 2025 Sustainability Report Highlighting Carbon Emission Reductions

5 Analyst Rating

Wall Street analysts forecast CLVT stock price to rise

0 Buy

3 Hold

2 Sell

Moderate Sell

Current: 0.000

Low

3.00

Averages

3.90

High

5.00

Current: 0.000

Low

3.00

Averages

3.90

High

5.00

Barclays

Manav Patnaik

Underweight

maintain

AI Analysis

2026-07-07

New

Reason

Barclays

Manav Patnaik

Price Target

AI Analysis

2026-07-07

New

maintain

Underweight

Reason

Barclays analyst Manav Patnaik raised the firm's price target on Clarivate to $2.50 from $2.40 and keeps an Underweight rating on the shares.

Citi

Neutral

downgrade

2026-03-04

Reason

Citi

Price Target

2026-03-04

downgrade

Neutral

Reason

Citi lowered the firm's price target on Clarivate to $2.80 from $4.25 and keeps a Neutral rating on the shares.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for CLVT

Unlock Now

Valuation Metrics

The current forward P/E ratio for Clarivate PLC (CLVT.N) is 3.55, compared to its 5-year average forward P/E of 11.87. For a more detailed relative valuation and DCF analysis to assess Clarivate PLC's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

dotted line Image

5Y Average PE

11.87

Current PE

3.55

Overvalued PE

19.37

Undervalued PE

4.36

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

dotted line Image

N/A

5Y Average EV/EBITDA

16.35

Current EV/EBITDA

46.85

Overvalued EV/EBITDA

33.42

Undervalued EV/EBITDA

-0.71

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

dotted line Image

5Y Average PS

2.46

Current PS

0.65

Overvalued PS

4.28

Undervalued PS

0.64

Financials

AI Analysis

Annual

Quarterly

Related Community Screener

idc. use whatever criteria and methods ne

Intellectia · 11 candidates

Market Cap: 50.00M - 2.00BRegion: USPrice: $0.10 - $5.00Market Cap Category: smallRelative Vol: >= 2List Exchange: XNYS, XNAS, XASESupport Resistance Relationship: PriceBreakResistanceOne Day Rise Prob: >= 60

Ticker

Name

Market Cap$

Honest Company Inc

316.05M

Century Therapeutics Inc

528.16M

Gevo Inc

543.92M

Prokidney Corp

718.99M

Clarivate PLC

1.67B

VTEX

692.11M

less than 3 usd

Intellectia · 1118 candidates

Price: <= $3.00

Ticker

Name

Market Cap$

Ambev SA

41.38B

Wipro Ltd

27.24B

Companhia Energetica De Minas Gerais-CEMIG

7.70B

Energy of Minas Gerais Co

5.98B

FuboTV Inc

3.33B

Plug Power Inc

3.09B

focus on growth and value

Intellectia · 28 candidates

Market Cap: >= 500.00MPrice: <= $5.00Revenue 5yr Cagr: >= 15Pe Ttm: <= 15

Ticker

Name

Market Cap$

NIO Inc

11.55B

Cosan SA

4.02B

FuboTV Inc

3.33B

Plug Power Inc

3.09B

Recursion Pharmaceuticals Inc

2.40B

Clarivate PLC

1.86B

I want to buy penny stock

Intellectia · 182 candidates

Market Cap: <= 2.00BPrice: <= $5.00Beta: HighRiskWeekly Average Turnover: >= 1,000,000Is Optionable: True

Ticker

Name

Market Cap$

Marqeta Inc

1.94B

Clarivate PLC

1.86B

Newell Brands Inc

1.79B

Grupo Televisa SAB

1.74B

Bitfarms Ltd

1.61B

Precigen Inc

1.58B

stocks that went down now

Intellectia · 25 candidates

Beta: HighRiskWeekly Average Turnover: >= 10,000,000Week Price Change Pct: <= $-7.00Month Price Change Pct: <= $-12.00Quarter Price Change Pct: <= $-20.00

Ticker

Name

Market Cap$

Oracle Corp

499.58B

Intuit Inc

146.07B

Constellation Energy Corp

106.67B

Robinhood Markets Inc

95.24B

Cloudflare Inc

59.54B

Atlassian Corp

32.21B

stocks between 2 $ and 3 $

Intellectia · 291 candidates

Price: $2.00 - $3.00

Ticker

Name

Market Cap$

Ambev SA

41.38B

Wipro Ltd

27.24B

Companhia Energetica De Minas Gerais-CEMIG

7.70B

Energy of Minas Gerais Co

5.98B

FuboTV Inc

3.33B

Plug Power Inc

3.09B

Best stock under 3.50 that will 3x

Intellectia · 29 candidates

Market Cap: <= 2.00BPrice: <= $3.50Beta: HighRiskRevenue 5yr Cagr: >= 20Annual Eps Yoy Growth: >= 20.0%

Ticker

Name

Market Cap$

Clarivate PLC

1.86B

Bitfarms Ltd

1.61B

Blend Labs Inc

732.49M

SNDL Inc

406.85M

Lineage Cell Therapeutics Inc

382.34M

SelectQuote Inc

283.31M

Whales Holding CLVT

BW Gestao de Investimentos Ltda.

Invenomic Capital Management LP

Timucuan Asset Management Inc

Lingotto Investment Management LLP

Trading Trends

People Also Watch

Frequently Asked Questions

What is Clarivate PLC (CLVT) stock price today?

The current price of CLVT is 2.51 USD — it has increased 2.87

What is Clarivate PLC (CLVT)'s business?

Clarivate Plc is a provider of transformative intelligence. The Company offers intelligence solutions, workflow solutions, and tech-enabled services to its customers. It operates through three segments, which include Academia & Government (A&G), Intellectual Property (IP), and Life Sciences & Healthcare (LS&H). The Academia & Government segment connects trusted content, responsible technology, and editorial expertise to fuel academic success and advance national outcomes for institutions and users around the world. The Intellectual Property segment provides intellectual property data, software, and helps companies drive innovation, law firms achieve practice excellence, and organizations manage and protect critical intellectual property assets. The Life Sciences & Healthcare segment offers life sciences and healthcare organizations with the contextual intelligence needed to deliver safe and commercial treatments and solutions to patients.

What is the price predicton of CLVT Stock?

Wall Street analysts forecast CLVT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CLVT is3.90 USD with a low forecast of 3.00 USD and a high forecast of 5.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Clarivate PLC (CLVT)'s revenue for the last quarter?

Clarivate PLC revenue for the last quarter amounts to 585.50M USD, decreased -1.38

What is Clarivate PLC (CLVT)'s earnings per share (EPS) for the last quarter?

Clarivate PLC. EPS for the last quarter amounts to -0.06 USD, decreased -60.00

How many employees does Clarivate PLC (CLVT). have?

Clarivate PLC (CLVT) has 12000 emplpoyees as of July 08 2026.

What is Clarivate PLC (CLVT) market cap?

Today CLVT has the market capitalization of 1.60B USD.